<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d356" origId="Atorvastatin"><sentence id="DrugDDI.d356.s0" origId="s0" text="The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, azole antifungals."><entity id="DrugDDI.d356.s0.e0" origId="s0.p3" charOffset="43-48" type="drug" text="drugs"/><entity id="DrugDDI.d356.s0.e1" origId="s0.p8" charOffset="110-122" type="drug" text="cyclosporine"/><entity id="DrugDDI.d356.s0.e2" origId="s0.p9" charOffset="136-147" type="drug" text="derivatives"/><entity id="DrugDDI.d356.s0.e3" origId="s0.p10" charOffset="149-155" type="drug" text="niacin"/><entity id="DrugDDI.d356.s0.e4" origId="s0.p12" charOffset="157-171" type="drug" text="nicotinic acid"/><entity id="DrugDDI.d356.s0.e5" origId="s0.p15" charOffset="174-186" type="drug" text="erythromycin"/><entity id="DrugDDI.d356.s0.e6" origId="s0.p16" charOffset="188-205" type="drug" text="azole antifungals"/><pair id="DrugDDI.d356.s0.p0" e1="DrugDDI.d356.s0.e0" e2="DrugDDI.d356.s0.e1" interaction="true"/><pair id="DrugDDI.d356.s0.p1" e1="DrugDDI.d356.s0.e0" e2="DrugDDI.d356.s0.e2" interaction="false"/><pair id="DrugDDI.d356.s0.p2" e1="DrugDDI.d356.s0.e0" e2="DrugDDI.d356.s0.e3" interaction="true"/><pair id="DrugDDI.d356.s0.p3" e1="DrugDDI.d356.s0.e0" e2="DrugDDI.d356.s0.e4" interaction="false"/><pair id="DrugDDI.d356.s0.p4" e1="DrugDDI.d356.s0.e0" e2="DrugDDI.d356.s0.e5" interaction="true"/><pair id="DrugDDI.d356.s0.p5" e1="DrugDDI.d356.s0.e0" e2="DrugDDI.d356.s0.e6" interaction="false"/><pair id="DrugDDI.d356.s0.p6" e1="DrugDDI.d356.s0.e1" e2="DrugDDI.d356.s0.e2" interaction="false"/><pair id="DrugDDI.d356.s0.p7" e1="DrugDDI.d356.s0.e1" e2="DrugDDI.d356.s0.e3" interaction="false"/><pair id="DrugDDI.d356.s0.p8" e1="DrugDDI.d356.s0.e1" e2="DrugDDI.d356.s0.e4" interaction="false"/><pair id="DrugDDI.d356.s0.p9" e1="DrugDDI.d356.s0.e1" e2="DrugDDI.d356.s0.e5" interaction="false"/><pair id="DrugDDI.d356.s0.p10" e1="DrugDDI.d356.s0.e1" e2="DrugDDI.d356.s0.e6" interaction="false"/><pair id="DrugDDI.d356.s0.p11" e1="DrugDDI.d356.s0.e2" e2="DrugDDI.d356.s0.e3" interaction="false"/><pair id="DrugDDI.d356.s0.p12" e1="DrugDDI.d356.s0.e2" e2="DrugDDI.d356.s0.e4" interaction="false"/><pair id="DrugDDI.d356.s0.p13" e1="DrugDDI.d356.s0.e2" e2="DrugDDI.d356.s0.e5" interaction="false"/><pair id="DrugDDI.d356.s0.p14" e1="DrugDDI.d356.s0.e2" e2="DrugDDI.d356.s0.e6" interaction="false"/><pair id="DrugDDI.d356.s0.p15" e1="DrugDDI.d356.s0.e3" e2="DrugDDI.d356.s0.e4" interaction="false"/><pair id="DrugDDI.d356.s0.p16" e1="DrugDDI.d356.s0.e3" e2="DrugDDI.d356.s0.e5" interaction="false"/><pair id="DrugDDI.d356.s0.p17" e1="DrugDDI.d356.s0.e3" e2="DrugDDI.d356.s0.e6" interaction="false"/><pair id="DrugDDI.d356.s0.p18" e1="DrugDDI.d356.s0.e4" e2="DrugDDI.d356.s0.e5" interaction="false"/><pair id="DrugDDI.d356.s0.p19" e1="DrugDDI.d356.s0.e4" e2="DrugDDI.d356.s0.e6" interaction="false"/><pair id="DrugDDI.d356.s0.p20" e1="DrugDDI.d356.s0.e5" e2="DrugDDI.d356.s0.e6" interaction="false"/></sentence><sentence id="DrugDDI.d356.s1" origId="s1" text="Antacid: When atorvastatin and Maalox? TC suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%."><entity id="DrugDDI.d356.s1.e0" origId="s1.p17" charOffset="0-7" type="drug" text="Antacid"/><entity id="DrugDDI.d356.s1.e1" origId="s1.p20" charOffset="14-26" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s1.e2" origId="s1.p27" charOffset="99-111" type="drug" text="atorvastatin"/><pair id="DrugDDI.d356.s1.p0" e1="DrugDDI.d356.s1.e0" e2="DrugDDI.d356.s1.e1" interaction="false"/><pair id="DrugDDI.d356.s1.p1" e1="DrugDDI.d356.s1.e0" e2="DrugDDI.d356.s1.e2" interaction="false"/><pair id="DrugDDI.d356.s1.p2" e1="DrugDDI.d356.s1.e1" e2="DrugDDI.d356.s1.e2" interaction="false"/></sentence><sentence id="DrugDDI.d356.s2" origId="s2" text="However, LDL-C reduction was not altered."/><sentence id="DrugDDI.d356.s3" origId="s3" text="Antipyrine: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected."><entity id="DrugDDI.d356.s3.e0" origId="s3.p35" charOffset="0-10" type="drug" text="Antipyrine"/><entity id="DrugDDI.d356.s3.e1" origId="s3.p38" charOffset="20-32" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s3.e2" origId="s3.p43" charOffset="73-83" type="drug" text="antipyrine"/><entity id="DrugDDI.d356.s3.e3" origId="s3.p45" charOffset="109-114" type="drug" text="drugs"/><entity id="DrugDDI.d356.s3.e4" origId="s3.p47" charOffset="151-159" type="drug" text="isozymes"/><pair id="DrugDDI.d356.s3.p0" e1="DrugDDI.d356.s3.e0" e2="DrugDDI.d356.s3.e1" interaction="false"/><pair id="DrugDDI.d356.s3.p1" e1="DrugDDI.d356.s3.e0" e2="DrugDDI.d356.s3.e2" interaction="false"/><pair id="DrugDDI.d356.s3.p2" e1="DrugDDI.d356.s3.e0" e2="DrugDDI.d356.s3.e3" interaction="false"/><pair id="DrugDDI.d356.s3.p3" e1="DrugDDI.d356.s3.e0" e2="DrugDDI.d356.s3.e4" interaction="false"/><pair id="DrugDDI.d356.s3.p4" e1="DrugDDI.d356.s3.e1" e2="DrugDDI.d356.s3.e2" interaction="false"/><pair id="DrugDDI.d356.s3.p5" e1="DrugDDI.d356.s3.e1" e2="DrugDDI.d356.s3.e3" interaction="false"/><pair id="DrugDDI.d356.s3.p6" e1="DrugDDI.d356.s3.e1" e2="DrugDDI.d356.s3.e4" interaction="false"/><pair id="DrugDDI.d356.s3.p7" e1="DrugDDI.d356.s3.e2" e2="DrugDDI.d356.s3.e3" interaction="false"/><pair id="DrugDDI.d356.s3.p8" e1="DrugDDI.d356.s3.e2" e2="DrugDDI.d356.s3.e4" interaction="false"/><pair id="DrugDDI.d356.s3.p9" e1="DrugDDI.d356.s3.e3" e2="DrugDDI.d356.s3.e4" interaction="false"/></sentence><sentence id="DrugDDI.d356.s4" origId="s4" text="Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered."><entity id="DrugDDI.d356.s4.e0" origId="s4.p51" charOffset="0-10" type="drug" text="Colestipol"/><entity id="DrugDDI.d356.s4.e1" origId="s4.p54" charOffset="37-49" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s4.e2" origId="s4.p58" charOffset="83-93" type="drug" text="colestipol"/><entity id="DrugDDI.d356.s4.e3" origId="s4.p60" charOffset="98-110" type="drug" text="atorvastatin"/><pair id="DrugDDI.d356.s4.p0" e1="DrugDDI.d356.s4.e0" e2="DrugDDI.d356.s4.e1" interaction="false"/><pair id="DrugDDI.d356.s4.p1" e1="DrugDDI.d356.s4.e0" e2="DrugDDI.d356.s4.e2" interaction="false"/><pair id="DrugDDI.d356.s4.p2" e1="DrugDDI.d356.s4.e0" e2="DrugDDI.d356.s4.e3" interaction="false"/><pair id="DrugDDI.d356.s4.p3" e1="DrugDDI.d356.s4.e1" e2="DrugDDI.d356.s4.e2" interaction="false"/><pair id="DrugDDI.d356.s4.p4" e1="DrugDDI.d356.s4.e1" e2="DrugDDI.d356.s4.e3" interaction="false"/><pair id="DrugDDI.d356.s4.p5" e1="DrugDDI.d356.s4.e2" e2="DrugDDI.d356.s4.e3" interaction="true"/></sentence><sentence id="DrugDDI.d356.s5" origId="s5" text="However, LDL-C reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone."><entity id="DrugDDI.d356.s5.e0" origId="s5.p68" charOffset="42-54" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s5.e1" origId="s5.p70" charOffset="59-69" type="drug" text="colestipol"/><entity id="DrugDDI.d356.s5.e2" origId="s5.p76" charOffset="107-111" type="drug" text="drug"/><pair id="DrugDDI.d356.s5.p0" e1="DrugDDI.d356.s5.e0" e2="DrugDDI.d356.s5.e1" interaction="true"/><pair id="DrugDDI.d356.s5.p1" e1="DrugDDI.d356.s5.e0" e2="DrugDDI.d356.s5.e2" interaction="false"/><pair id="DrugDDI.d356.s5.p2" e1="DrugDDI.d356.s5.e1" e2="DrugDDI.d356.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d356.s6" origId="s6" text="Cimetidine: Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of cimetidine."><entity id="DrugDDI.d356.s6.e0" origId="s6.p80" charOffset="0-10" type="drug" text="Cimetidine"/><entity id="DrugDDI.d356.s6.e1" origId="s6.p82" charOffset="12-24" type="drug" text="Atorvastatin"/><entity id="DrugDDI.d356.s6.e2" origId="s6.p89" charOffset="107-117" type="drug" text="cimetidine"/><pair id="DrugDDI.d356.s6.p0" e1="DrugDDI.d356.s6.e0" e2="DrugDDI.d356.s6.e1" interaction="false"/><pair id="DrugDDI.d356.s6.p1" e1="DrugDDI.d356.s6.e0" e2="DrugDDI.d356.s6.e2" interaction="false"/><pair id="DrugDDI.d356.s6.p2" e1="DrugDDI.d356.s6.e1" e2="DrugDDI.d356.s6.e2" interaction="true"/></sentence><sentence id="DrugDDI.d356.s7" origId="s7" text="Digoxin: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%."><entity id="DrugDDI.d356.s7.e0" origId="s7.p90" charOffset="0-7" type="drug" text="Digoxin"/><entity id="DrugDDI.d356.s7.e1" origId="s7.p94" charOffset="32-44" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s7.e2" origId="s7.p96" charOffset="49-56" type="drug" text="digoxin"/><entity id="DrugDDI.d356.s7.e3" origId="s7.p100" charOffset="98-105" type="drug" text="digoxin"/><pair id="DrugDDI.d356.s7.p0" e1="DrugDDI.d356.s7.e0" e2="DrugDDI.d356.s7.e1" interaction="false"/><pair id="DrugDDI.d356.s7.p1" e1="DrugDDI.d356.s7.e0" e2="DrugDDI.d356.s7.e2" interaction="false"/><pair id="DrugDDI.d356.s7.p2" e1="DrugDDI.d356.s7.e0" e2="DrugDDI.d356.s7.e3" interaction="false"/><pair id="DrugDDI.d356.s7.p3" e1="DrugDDI.d356.s7.e1" e2="DrugDDI.d356.s7.e2" interaction="true"/><pair id="DrugDDI.d356.s7.p4" e1="DrugDDI.d356.s7.e1" e2="DrugDDI.d356.s7.e3" interaction="false"/><pair id="DrugDDI.d356.s7.p5" e1="DrugDDI.d356.s7.e2" e2="DrugDDI.d356.s7.e3" interaction="false"/></sentence><sentence id="DrugDDI.d356.s8" origId="s8" text="Patients taking digoxin should be monitored appropriately."><entity id="DrugDDI.d356.s8.e0" origId="s8.p105" charOffset="16-23" type="drug" text="digoxin"/></sentence><sentence id="DrugDDI.d356.s9" origId="s9" text="Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4."><entity id="DrugDDI.d356.s9.e0" origId="s9.p110" charOffset="0-12" type="drug" text="Erythromycin"/><entity id="DrugDDI.d356.s9.e1" origId="s9.p114" charOffset="63-75" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s9.e2" origId="s9.p118" charOffset="129-141" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s9.e3" origId="s9.p120" charOffset="146-158" type="drug" text="erythromycin"/><entity id="DrugDDI.d356.s9.e4" origId="s9.p122" charOffset="181-200" type="drug" text="cytochrome P450 3A4"/><pair id="DrugDDI.d356.s9.p0" e1="DrugDDI.d356.s9.e0" e2="DrugDDI.d356.s9.e1" interaction="false"/><pair id="DrugDDI.d356.s9.p1" e1="DrugDDI.d356.s9.e0" e2="DrugDDI.d356.s9.e2" interaction="false"/><pair id="DrugDDI.d356.s9.p2" e1="DrugDDI.d356.s9.e0" e2="DrugDDI.d356.s9.e3" interaction="false"/><pair id="DrugDDI.d356.s9.p3" e1="DrugDDI.d356.s9.e0" e2="DrugDDI.d356.s9.e4" interaction="false"/><pair id="DrugDDI.d356.s9.p4" e1="DrugDDI.d356.s9.e1" e2="DrugDDI.d356.s9.e2" interaction="false"/><pair id="DrugDDI.d356.s9.p5" e1="DrugDDI.d356.s9.e1" e2="DrugDDI.d356.s9.e3" interaction="false"/><pair id="DrugDDI.d356.s9.p6" e1="DrugDDI.d356.s9.e1" e2="DrugDDI.d356.s9.e4" interaction="false"/><pair id="DrugDDI.d356.s9.p7" e1="DrugDDI.d356.s9.e2" e2="DrugDDI.d356.s9.e3" interaction="true"/><pair id="DrugDDI.d356.s9.p8" e1="DrugDDI.d356.s9.e2" e2="DrugDDI.d356.s9.e4" interaction="false"/><pair id="DrugDDI.d356.s9.p9" e1="DrugDDI.d356.s9.e3" e2="DrugDDI.d356.s9.e4" interaction="false"/></sentence><sentence id="DrugDDI.d356.s10" origId="s10" text="Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%."><entity id="DrugDDI.d356.s10.e0" origId="s10.p123" charOffset="0-19" type="drug" text="oral contraceptives"/><entity id="DrugDDI.d356.s10.e1" origId="s10.p126" charOffset="41-53" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s10.e2" origId="s10.p128" charOffset="61-79" type="drug" text="oral contraceptive"/><entity id="DrugDDI.d356.s10.e3" origId="s10.p129" charOffset="105-118" type="drug" text="norethindrone"/><entity id="DrugDDI.d356.s10.e4" origId="s10.p131" charOffset="123-140" type="drug" text="ethinyl estradiol"/><pair id="DrugDDI.d356.s10.p0" e1="DrugDDI.d356.s10.e0" e2="DrugDDI.d356.s10.e1" interaction="false"/><pair id="DrugDDI.d356.s10.p1" e1="DrugDDI.d356.s10.e0" e2="DrugDDI.d356.s10.e2" interaction="false"/><pair id="DrugDDI.d356.s10.p2" e1="DrugDDI.d356.s10.e0" e2="DrugDDI.d356.s10.e3" interaction="false"/><pair id="DrugDDI.d356.s10.p3" e1="DrugDDI.d356.s10.e0" e2="DrugDDI.d356.s10.e4" interaction="false"/><pair id="DrugDDI.d356.s10.p4" e1="DrugDDI.d356.s10.e1" e2="DrugDDI.d356.s10.e2" interaction="true"/><pair id="DrugDDI.d356.s10.p5" e1="DrugDDI.d356.s10.e1" e2="DrugDDI.d356.s10.e3" interaction="false"/><pair id="DrugDDI.d356.s10.p6" e1="DrugDDI.d356.s10.e1" e2="DrugDDI.d356.s10.e4" interaction="false"/><pair id="DrugDDI.d356.s10.p7" e1="DrugDDI.d356.s10.e2" e2="DrugDDI.d356.s10.e3" interaction="false"/><pair id="DrugDDI.d356.s10.p8" e1="DrugDDI.d356.s10.e2" e2="DrugDDI.d356.s10.e4" interaction="false"/><pair id="DrugDDI.d356.s10.p9" e1="DrugDDI.d356.s10.e3" e2="DrugDDI.d356.s10.e4" interaction="false"/></sentence><sentence id="DrugDDI.d356.s11" origId="s11" text="These increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin."><entity id="DrugDDI.d356.s11.e0" origId="s11.p141" charOffset="55-73" type="drug" text="oral contraceptive"/><entity id="DrugDDI.d356.s11.e1" origId="s11.p142" charOffset="93-105" type="drug" text="atorvastatin"/><pair id="DrugDDI.d356.s11.p0" e1="DrugDDI.d356.s11.e0" e2="DrugDDI.d356.s11.e1" interaction="true"/></sentence><sentence id="DrugDDI.d356.s12" origId="s12" text="Warfarin: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment."><entity id="DrugDDI.d356.s12.e0" origId="s12.p143" charOffset="0-8" type="drug" text="Warfarin"/><entity id="DrugDDI.d356.s12.e1" origId="s12.p145" charOffset="10-22" type="drug" text="Atorvastatin"/><pair id="DrugDDI.d356.s12.p0" e1="DrugDDI.d356.s12.e0" e2="DrugDDI.d356.s12.e1" interaction="false"/></sentence><sentence id="DrugDDI.d356.s13" origId="s13" text="Endocrine Function HMG-CoA reductase inhibitors interfere with cholesterol synthesis and theoretically might blunt adrenal and/or gonadal steroid production."><entity id="DrugDDI.d356.s13.e0" origId="s13.p154" charOffset="19-47" type="drug" text="HMG-CoA reductase inhibitors"/><entity id="DrugDDI.d356.s13.e1" origId="s13.p156" charOffset="63-74" type="drug" text="cholesterol"/><entity id="DrugDDI.d356.s13.e2" origId="s13.p160" charOffset="115-122" type="drug" text="adrenal"/><pair id="DrugDDI.d356.s13.p0" e1="DrugDDI.d356.s13.e0" e2="DrugDDI.d356.s13.e1" interaction="true"/><pair id="DrugDDI.d356.s13.p1" e1="DrugDDI.d356.s13.e0" e2="DrugDDI.d356.s13.e2" interaction="false"/><pair id="DrugDDI.d356.s13.p2" e1="DrugDDI.d356.s13.e1" e2="DrugDDI.d356.s13.e2" interaction="false"/></sentence><sentence id="DrugDDI.d356.s14" origId="s14" text="Clinical studies have shown that atorvastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve."><entity id="DrugDDI.d356.s14.e0" origId="s14.p166" charOffset="33-45" type="drug" text="atorvastatin"/><entity id="DrugDDI.d356.s14.e1" origId="s14.p170" charOffset="75-83" type="drug" text="cortisol"/><entity id="DrugDDI.d356.s14.e2" origId="s14.p173" charOffset="108-115" type="drug" text="adrenal"/><pair id="DrugDDI.d356.s14.p0" e1="DrugDDI.d356.s14.e0" e2="DrugDDI.d356.s14.e1" interaction="false"/><pair id="DrugDDI.d356.s14.p1" e1="DrugDDI.d356.s14.e0" e2="DrugDDI.d356.s14.e2" interaction="false"/><pair id="DrugDDI.d356.s14.p2" e1="DrugDDI.d356.s14.e1" e2="DrugDDI.d356.s14.e2" interaction="false"/></sentence><sentence id="DrugDDI.d356.s15" origId="s15" text="The effects of HMG-CoA reductase inhibitors on male fertility have not been studied in adequate numbers of patients."><entity id="DrugDDI.d356.s15.e0" origId="s15.p175" charOffset="15-43" type="drug" text="HMG-CoA reductase inhibitors"/></sentence><sentence id="DrugDDI.d356.s16" origId="s16" text="The effects, if any, on the pituitary-gonadal axis in premenopausal women are unknown."/><sentence id="DrugDDI.d356.s17" origId="s17" text="Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine."><entity id="DrugDDI.d356.s17.e0" origId="s17.p194" charOffset="34-61" type="drug" text="hmg-coa reductase inhibitor"/><entity id="DrugDDI.d356.s17.e1" origId="s17.p198" charOffset="97-102" type="drug" text="drugs"/><entity id="DrugDDI.d356.s17.e2" origId="s17.p206" charOffset="184-196" type="drug" text="ketoconazole"/><entity id="DrugDDI.d356.s17.e3" origId="s17.p207" charOffset="198-212" type="drug" text="spironolactone"/><entity id="DrugDDI.d356.s17.e4" origId="s17.p209" charOffset="218-228" type="drug" text="cimetidine"/><pair id="DrugDDI.d356.s17.p0" e1="DrugDDI.d356.s17.e0" e2="DrugDDI.d356.s17.e1" interaction="true"/><pair id="DrugDDI.d356.s17.p1" e1="DrugDDI.d356.s17.e0" e2="DrugDDI.d356.s17.e2" interaction="false"/><pair id="DrugDDI.d356.s17.p2" e1="DrugDDI.d356.s17.e0" e2="DrugDDI.d356.s17.e3" interaction="true"/><pair id="DrugDDI.d356.s17.p3" e1="DrugDDI.d356.s17.e0" e2="DrugDDI.d356.s17.e4" interaction="false"/><pair id="DrugDDI.d356.s17.p4" e1="DrugDDI.d356.s17.e1" e2="DrugDDI.d356.s17.e2" interaction="false"/><pair id="DrugDDI.d356.s17.p5" e1="DrugDDI.d356.s17.e1" e2="DrugDDI.d356.s17.e3" interaction="false"/><pair id="DrugDDI.d356.s17.p6" e1="DrugDDI.d356.s17.e1" e2="DrugDDI.d356.s17.e4" interaction="false"/><pair id="DrugDDI.d356.s17.p7" e1="DrugDDI.d356.s17.e2" e2="DrugDDI.d356.s17.e3" interaction="false"/><pair id="DrugDDI.d356.s17.p8" e1="DrugDDI.d356.s17.e2" e2="DrugDDI.d356.s17.e4" interaction="false"/><pair id="DrugDDI.d356.s17.p9" e1="DrugDDI.d356.s17.e3" e2="DrugDDI.d356.s17.e4" interaction="false"/></sentence><sentence id="DrugDDI.d356.s18" origId="s18" text="CNS Toxicity Brain hemorrhage was seen in a female dog treated for 3 months at 120 mg/kg/day."/><sentence id="DrugDDI.d356.s19" origId="s19" text="Brain hemorrhage and optic nerve vacuolation were seen in another female dog that was sacrificed in moribund condition after 11 weeks of escalating doses up to 280 mg/kg/day."/><sentence id="DrugDDI.d356.s20" origId="s20" text="The 120 mg/kg dose resulted in a systemic exposure approximately 16 times the human plasma area-under-the-curve (AUC, 0-24 hours) based on the maximum human dose of 80 mg/day."><entity id="DrugDDI.d356.s20.e0" origId="s20.p238" charOffset="78-90" type="drug" text="human plasma"/></sentence><sentence id="DrugDDI.d356.s21" origId="s21" text="A single tonic convulsion was seen in each of 2 male dogs (one treated at 10 mg/kg/day and one at 120 mg/kg/day) in a 2-year study."/><sentence id="DrugDDI.d356.s22" origId="s22" text="No CNS lesions have been observed in mice after chronic treatment for up to 2 years at doses up to 400 mg/kg/day or in rats at doses up to 100 mg/kg/day."/><sentence id="DrugDDI.d356.s23" origId="s23" text="These doses were 6 to 11 times (mouse) and 8 to 16 times (rat) the human AUC (0-24) based on the maximum recommended human dose of 80 mg/day."/><sentence id="DrugDDI.d356.s24" origId="s24" text="CNS vascular lesions, characterized by perivascular hemorrhages, edema, and mononuclear cell infiltration of perivascular spaces, have been observed in dogs treated with other members of this class."/><sentence id="DrugDDI.d356.s25" origId="s25" text="A chemically similar drug in this class produced optic nerve degeneration (Wallerian degeneration of retinogeniculate fibers) in clinically normal dogs in a dose-dependent fashion at a dose that produced plasma drug levels about 30 times higher than the mean drug level in humans taking the highest recommended dose."><entity id="DrugDDI.d356.s25.e0" origId="s25.p321" charOffset="21-25" type="drug" text="drug"/></sentence></document>